La catena delle opzioni mostra i dati chiave delle opzioni azionarie di ENDRA Life Sciences a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per ENDRA Life Sciences..

ENDRA Life Sciences (NASDAQ:NDRA) Azioni, Catena delle Opzioni

ENDRA Life Sciences

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

ENDRA Life Sciences Inc

President-elect Donald Trump has announced many of his picks for potential nominees for his Cabinet and other White House administration roles since winning the<a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election"> 2024 presidential election.</a>
While the picks still have to be officially nominated and approved in many cases, voters were recently asked to share whether they approve or disapprove of his current selections.
What Happened: Trump's announced picks have generated plenty of discussion on social media and across the political spectrum with the announced pick of Matt Gaetz as attorney general eventually saw the former Congressman <a href="https://www.benzinga.com/politics/24/11/42170037/elon-musk-said-matt-gaetz-would-be-hammer-of-justice-as-attorney-general-former-congressman-now-unemployed-sells-cameos-for-500">withdraw his name </a>due to concerns of being a distraction and fears of not getting approval.
A new Morning Consult poll asked voters for their approval ratings on Trump and his picks for the new White House administration.
The <a href="https://pro.morningconsult.com/analysis/rfk-jr-hhs-polling-november-2024">poll </a>found Trump had an approval rating of 53%, down from 54% in <a href="https://www.benzinga.com/politics/24/11/42077496/donald-trumps-personnel-picks-new-poll-finds-elon-musk-with-highest-approval-by-voters-matt-gaetz-with-highest-disapproval">the poll published</a> on Nov. 17. Split by political party, Republicans gave Trump a 91% approval rating, down from 93%, Independents gave an approval rating of 44%, down from 46% and Democrats gave an approval rating of 21%, up from 20%.
Personnel Pick Ratings: Here are the approval and disapproval ratings of recent personnel picks by Trump for his next White House term.
<ul>
<li>Marco Rubio, Secretary of State: 45% approval, 34% disapproval, 21% no opinion</li>
<li>Robert F. Kennedy Jr., Health and Human Services Secretary: 44% approval, 39% disapproval, 17% no opinion</li>
<li>Mike Huckabee, U.S. ambassador to Isreal: 44% approval, 31% disapproval, 25% no opinion</li>
<li>Mehmet Oz, CMS administrator: 41% approval, 38% disapproval, 20% no opinion</li>
<li>Tulsi Gabbard, Director of National Intelligence: 39% approval, 33% disapproval, 29% no opinion</li>
<li>Pam Bondi, Attorney General: 39% approval, 29% disapproval, 33% no opinion</li>
<li>Elise Stefanik, U.S. ambassador to the United Nations: 38% approval, 29% disapproval, 33% no opinion</li>
<li>Kristi Noem, Homeland Security secretary: 37% approval, 33% disapproval, 30% no opinion</li>
<li>Pete Hegseth, Defense secretary: 36% approval, 32% disapproval, 32% no opinion</li>
<li>Linda McMahon, Education secretary: 36% approval, 36% disapproval, 28% no opinion</li>
<li>Scott Bessent, Treasury secretary: 36% approval, 25% disapproval, 39% no opinion</li>
<li>Doug Collins, Veterans Affairs secretary: 35% approval, 25% disapproval, 40% no opinion</li>
<li>Doug Burgum, Interior secretary: 35% approval, 26% disapproval, 39% no opinion</li>
<li>Janette Nesheiwat, Surgeon General: 35% approval, 25% disapproval, 40% no opinion</li>
<li>Matt Whitaker, NATO ambassador: 34% approval, 28% disapproval, 38% no opinion</li>
<li>Sean Duffy, Transportation secretary: 34% approval, 28% disapproval, 38% no opinion</li>
<li>Chris Wright, Energy secretary, 34% approval, 29% disapproval, 37% no opinion</li>
<li>Lee Zeldin, EPA administrator: 34% approval, 29% disapproval, 37% no opinion</li>
<li>Brooke Rollins, Agriculture secretary: 34% approval, 24% disapproval, 43% no opinion</li>
<li>Marty Makary, FDA commissioner: 33% approval, 27% disapproval, 40% no opinion</li>
<li>Dave Weldon, CDC director: 33% approval, 27% disapproval, 40% no opinion</li>
<li>Howard Lutnick, Commerce secretary: 33% approval, 25% disapproval, 42% no opinion</li>
<li>Russell Vought, Office of Management and Budget director: 33% approval, 26% disapproval, 41% no opinion</li>
<li>Scott Turner, Housing and Urban Development secretary: 33% approval, 26% disapproval, 41% no opinion</li>
<li>Brendan Carr, FCC chair: 32% approval, 26% disapproval, 42% no opinion</li>
</ul>
The new results did not include Elon Musk and Vivek Ramaswamy, co-leaders of the Department of Government Efficiency. In the<a href="https://www.benzinga.com/politics/24/11/42077496/donald-trumps-personnel-picks-new-poll-finds-elon-musk-with-highest-approval-by-voters-matt-gaetz-with-highest-disapproval"> previous poll</a>, Musk had approval rating of 45%, 40% disapproval and 15% said no opinion. Ramaswamy had a 39% approval rating, 34% disapproval and 27% said no opinion.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent120524">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: McMahon received a 36% approval and 36% disapproval as the only candidate to not have a higher approval than disapproval.
This could be bad news for the former WWE executive as the last poll saw Gaetz as the only person with a higher disapproval than approval rating at 41% and 34% respectively.
With Gaetz and Musk, who had a disapproval of 40% previously, no longer in the poll, it is Kennedy who has the highest disapproval followed by Oz and McMahon.
The highest approval ratings go to Rubio, Kennedy and Huckabee. The last poll also saw Rubio and Kennedy have the highest approval ratings.
Huckabee again has the highest net approval rating at 13 points, followed by Rubio at 11 points.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/11/42223923/trump-hhs-pick-robert-f-kennedy-jr-s-wealth-comes-from-family-law-practice-oil-bitcoin">Trump HHS Pick Robert F. Kennedy Jr.&#8217;s Wealth Comes From Family, Law Practice, Oil, Bitcoin</a></li>
</ul>
Photo: Shutterstock

Government

Politics

Management

Donald Trump's Personnel Picks: Voters Like Huckabee, Rubio Picks, Disapprove Of Kennedy, Oz, McMahon

The NFL and NFL Players Association (NFLPA) have agreed on updates to the league&#8217;s substance abuse policy, making it more lenient toward <a href="https://www.benzinga.com/cannabis">marijuana use. </a>
These changes include a significant increase in the THC testing threshold and reductions in financial penalties, reflecting a shift in how the league handles cannabis-related issues, NBC Sports <a href="https://www.nbcsports.com/nfl/profootballtalk/rumor-mill/news/nfl-takes-another-big-step-toward-legalizing-marijuana-use-by-players">reported.</a>
<h3 class="wp-block-heading">New THC Testing Limits</h3>
Players will now face fewer positive tests with the THC threshold rising from 150 nanograms per milliliter (ng/ml) to 350 ng/ml. 
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40558915/will-cannabis-be-a-game-changer-for-athletes-nfls-1m-study-suggests-it-could">Will Cannabis Be A Game-Changer For Athletes? NFL&#8217;s $1M Study Suggests It Could</a>
This adjustment, effective immediately, allows for a longer window after marijuana use before players might test positive (It typically takes about a week after regular use to drop below 350 ng/ml.).
<h3 class="wp-block-heading">Lower Fines For Violations</h3>
The financial penalties for positive tests have been reduced across the board:
<ul>
<li>First Violation: A fine of $15,000 instead of half a game check.</li>
<li>Second Violation: A $20,000 fine replaces a full game check penalty.</li>
<li>Third Violation: Players now face a single-game fine, down from two.</li>
<li>Fourth Violation or More: A two-game fine replaces the previous three-game penalty.</li>
</ul>
Missed tests will also result in lower fines under the revised policy.
<h3 class="wp-block-heading">Gradual Policy Shifts</h3>
These changes build on the NFL&#8217;s 2020 move to largely eliminate suspensions for marijuana use, making punishment less severe for players. While marijuana use isn't entirely unrestricted, the increase in THC limits and reduction in fines suggest a growing tolerance within the league.
Players must still meet the new THC threshold to avoid penalties, but the policy revisions signal a softer approach to cannabis testing.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/10/41403643/cannabis-can-be-a-great-tool-in-dealing-with-adversity-says-former-nfl-star-ricky-williams">Cannabis Can Be A &#8216;Great Tool In Dealing With Adversity,&#8217; Says Former NFL Star Ricky Williams</a></li>
</ul>
Cover image made with AI

Cannabis

News

Sports

Markets

General

NFL Eases Marijuana Rules: Is Full Legalization In The Game Plan?

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNOV#NASDAQ">MNOV</a>) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announces the study update and interim analysis results from the Company's COMBAT-ALS Phase 2b/3 clinical trial of MN-166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS) will be presented&nbsp;at the 35th International Symposium on ALS/MND held December 6-8, 2024 in Montreal, Canada.
The highlights of the presentation, titled, "COMBAT-ALS Phase 2b/3 Trial of MN-166 (Ibudilast) in ALS: Trial Update and Interim Analysis Results" (Abstract # 302), include:
<ul>
<li>Study Update: As of November 15, 2024, a total of 217 participants have been enrolled and 183 participants were assigned to either MN-166 or placebo group.</li>
<li>Pre-defined interim analysis was conducted to evaluate the correlation between the 6-month and 12-month data and assess the 12-month double-blind phase trial design.</li>
<li>A subset of patients from the full analysis set who had ALSFRS-R data at 6 months and at least one post-6-month data point. Correlation analysis of the Combined Assessment of Function and Survival (CAFS) scores at 6 and 12 months as well as modified CAFS scores and ALSFRS-R scores were evaluated.</li>
<li>Positive correlations were observed between the 6-month and 12-month data for CAFS score (0.71), modified CAFS score (0.70), and ALSFRS-R (0.69). [Note: Values in parentheses are Spearman Rank Correlation coefficients]</li>
<li>Positive correlations were also observed for Bulbar score (0.74), Fine motor score (0.71), and Gross motor score (0.67), but not for Respiratory score. [Note: Values in parentheses are Spearman Rank Correlation coefficients]</li>
<li>Interim analysis results were reviewed and validated by an external independent Data Safety Monitoring Board (DSMB), which recommended that the trial continue as per the protocol.</li>
</ul>

Biotech

MNOV

MediciNova Presents Study Update And Interim Analysis Of Phase 2/3 Clinical Trial Of MN-166 In ALS At The 35th International Symposium On ALS/MND

<ul>
<li>Teva entered into an agreement with JKI Co., Ltd. ("JKI") established by the fund managed and operated by private equity firm J-Will Partners Co., Ltd. ("J-Will"), through which JKI will acquire&nbsp;Teva-Takeda</li>
<li>The agreement is aligned with Teva's Pivot to Growth strategy to focus its business</li>
<li>The expected divestment of Teva-Takeda, Teva's business venture in Japan, which includes generics products and legacy products, will allow Teva to focus on bringing its innovative medicines to the Japanese market &nbsp;</li>
</ul>
TEL AVIV, Israel, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Today, Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced that it has entered into an agreement with JKI, established by the fund managed and operated by J-Will, whereby all shares of Teva Takeda Pharma Limited and its wholly owned subsidiary Teva Takeda Yakuhin Ltd. will be transferred to JKI.
Teva recently communicated that it was open to exploring new strategic approaches in Japan, including a possible divestment of its Teva-Takeda business venture, in alignment with its Pivot to Growth strategy. The divestment will allow Teva to focus on its innovative medicines business in Japan.
Teva expects the divestiture to be completed by 1 April, 2025, subject to standard closing conditions, including obtaining required regulatory approvals. All the employees of the business venture in Japan will remain employed, subject to the terms of the agreement.

Contracts

Global

TEVA

Teva Entered Into An Agreement With JKI Co. Established By The Fund Managed And Operated By Private Equity Firm J-Will Partners Co., Through Which JKI Will Acquire Teva-Takeda; The Agreement Is Aligned With Teva's Pivot To Growth Strategy To Focus Its Business; No Financial Terms Disclosed

The Illinois Supreme Court has decided that the smell of raw cannabis is enough for police to <a href="https://www.benzinga.com/markets/cannabis/24/10/41537177/research-finds-no-clear-correlation-between-blood-thc-and-driving-skills">search a vehicle. </a>
The ruling, which contrasts with an earlier decision that the smell of burnt cannabis is not enough for a search, has sparked legal and public debate over how cannabis laws are applied in the state, the Chicago Tribune <a href="https://www.chicagotribune.com/2024/12/05/police-may-search-a-vehicle-based-on-the-smell-of-raw-cannabis-illinois-supreme-court-rules/">reported.</a>
<h3 class="wp-block-heading">Two Cases, Two Different Outcomes</h3>
The decision stems from a case involving Vincent Molina, a passenger in a car stopped for speeding on I-88 near the Illinois-Iowa border in December 2020.
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/07/40055095/does-cannabis-affect-your-driving-university-of-colorado-researchers-find-out">Does Cannabis Affect Your Driving? University Of Colorado Researchers Find Out</a>
A state trooper claimed to smell cannabis through the open window, prompting a search that uncovered several joints and cannabis stored in a sealed box. While Illinois legalized small amounts of cannabis in 2020, Molina was charged with improper transport for not using an odor-proof container.
Initially, a court ruled the search unjustified. However, an appeals court reversed that decision, leading to <a href="https://www.benzinga.com/markets/cannabis/24/01/36593012/is-cannabis-odor-sufficient-cause-for-a-legal-vehicle-search-illinois-supreme-court-will-decide">the state Supreme Court's involvement.</a> The court ruled that the smell of raw cannabis strongly suggests a violation of Illinois law, which requires cannabis in vehicles to be stored in an odor-proof container.
In a separate case heard by the court, People v. Ryan Redmond, the justices ruled that the smell of burnt cannabis doesn't justify a vehicle search, as it could simply indicate prior use outside the vehicle.
<h3 class="wp-block-heading">Confusion Over Legal Standards</h3>
This split in rulings has drawn criticism. Justice Mary K. O'Brien, joined by Chief Justice Mary Jane Theis, dissented in the Molina case. "It makes no sense to treat raw cannabis as more probative when the odor of burnt cannabis may suggest recent use, whereas the odor of raw cannabis does not suggest consumption," O'Brien wrote.
Meanwhile, defense attorney James Mertes, stated: "This means that the privacy rights of motorists in Illinois have been turned over to the police officer's sense of smell," Mertes said. He plans to appeal the decision to the U.S. Supreme Court.
<h3 class="wp-block-heading">A Legislative Puzzle</h3>
Adding to the confusion,<a href="https://www.benzinga.com/markets/cannabis/23/03/31607966/wait-officer-weed-smell-no-longer-cause-for-vehicle-search-in-illinois-as-senate-approves-bill"> Illinois lawmakers previously removed</a> the odor-proof container requirement from the cannabis legalization law but left it in the vehicle code. The state Supreme Court suggested this legal mismatch needs fixing.
"I am discouraged by the Illinois Supreme Court's decision, but I am encouraged to now ask that this matter be decided by the United States Supreme Court," Molina said in a statement.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/02/36969871/is-weed-worse-than-alcohol-for-driving-new-study-challenges-common-dui-assumptions">Is Weed Worse Than Alcohol For Driving? New Study Challenges Common DUI Assumptions</a></li>
</ul>
Cover image made with AI.

Legal

Police Can Search Cars For Raw Cannabis Smell, Illinois Supreme Court Says

The National Football League is enjoying strong viewership for the 2024 season with some records set on Thanksgiving Day, news that streaming giant Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) likely welcomes as the company may be nervous after struggles with its<a href="https://www.benzinga.com/general/sports/24/11/42042640/netflix-crash-hits-jake-paul-mike-tyson-fight-can-streaming-platform-handle-christmas-day-nfl-action"> live boxing event.</a>
What Happened: While many people will be opening presents and enjoying time with families on Christmas Day, many will also tune into Netflix for <a href="https://www.benzinga.com/general/entertainment/24/05/38850110/netflix-to-stream-2-nfl-christmas-day-games-analyst-sees-strong-growth-potential">two exclusive NFL games</a>, similar to how they celebrated on Thanksgiving.
Netflix will stream its first-ever live NFL games on Christmas with two key matchups that could once again highlight the streaming giant's growth in sports.
At 1 p.m. ET, the Pittsburgh Steelers and Kansas City Chiefs game will stream on Netflix, followed by the 4:30 p.m. ET matchup between the Baltimore Ravens and Houston Texans.
NFL viewership has been good for the 2024 season, which could be good and bad for Netflix as the company struggled during its recent live boxing event that featured a headline match between Jake Paul and Mike Tyson.
Netflix reported that over 60 million homes tuned into the boxing event, with a peak of 65 million. That event saw hundreds of thousands of people report issues with the stream and a class action lawsuit filed against the company.
The NFL recently <a href="https://media.nfl.com/news-and-releases/corporate-communications/2024-thanksgiving-day-games-set-viewership-records">reported </a>the three games that aired on Thanksgiving set a new all-time record, with data dating back to 1988. The three games had 141 million viewers, a new record and an average of 34.2 million viewers per game, another record.
The early game between the Detroit Lions and Chicago Bears on CBS, a unit of Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARAA#NASDAQ">PARAA</a>), set a record with 37.5 million viewers, the highest average for the early Thanksgiving Day game.
The midday game between the Dallas Cowboys and New York Giants on FOX, a unit of Fox Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOX#NASDAQ">FOX</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXA#NASDAQ">FOXA</a>), averaged 38.8 million viewers, making it the fourth most watched Thanksgiving Day game ever and fifth most watched regular season NFL game ever.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41235640/netflix-to-become-default-choice-for-tv-movies-analyst-predicts-more-live-sports-pr">Netflix To Become &#8216;Default Choice&#8217; For TV, Movies? Analyst Predicts More Live Sports, Price Increases</a>
Why It's Important: Thanksgiving Day games have long been highly watched given the event-driven nature of the games on a holiday with people off work and watching games together.
This could be similar on Christmas, which means Netflix could be in store for high viewership for its inaugural NFL games.
For comparison, Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) has the exclusive streaming rights to Thursday Night Football games and is averaging 13.3 million viewers for those games this season, up 8% year-over-year.
Amazon also streamed an exclusive game on Black Friday for the second straight year. The matchup between the Las Vegas Raiders and Kansas City Chiefs <a href="https://frontofficesports.com/amazons-nfl-black-friday-game-ratings-up-41-from-2023/">averaged </a>13.51 million viewers, up 41% year-over-year.
The high viewership, which is above Amazon's average, came with a close battle and the Chiefs surviving a last-minute push from the Raiders. The Chiefs are the most-watched NFL team this season, having some of the more popular games and the highest average across national television games.
For Netflix the odds are likely stacked for and against the company to have huge viewership, the big question is if the company can handle the demand and show the games without the same troubles it had during the boxing event.
The Chiefs (11-1), Steelers (9-3), Ravens (8-5) and Texans (8-5) are among the best teams in the NFL with each team ranking first or second in their division and all four teams currently in the NFL Playoffs if the season ended today.
The Texans game will also feature a halftime performance from Beyoncé, adding in potential non-football fan viewership on the holiday.
Add it all up and you have two games with top NFL teams, a holiday where people watch sports together, a halftime performance from a global superstar, a game with the top-watched team in the NFL and the potential of Taylor Swift to be present at the Chiefs game and you have must-see television and sports.
NFLX Price Action: Netflix stock closed up 0.75% to $917.87 on Thursday after hitting new all-time highs of $927 during the intraday. Netflix stock is up 96% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/12/42305013/squid-game-season-2-includes-new-games-contestant-with-a-crypto-background-revenge-factor-political-overtones">&#8216;Squid Game&#8217; Season 2 Includes New Games, Contestant With A Crypto Background, Revenge Factor, Political Overtones</a></li>
</ul>
Photo: Shutterstock

Entertainment

Media

Trading Ideas

AMZN

FOXA

NFLX

PARA

PARAA

NFL Games Set Thanksgiving Day Records: Why This Is Good And Bad News For Streaming Giant Netflix

Asana, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) reported its third-quarter results after Thursday's closing bell. Here's a look at the details <a href="https://www.benzinga.com/pressreleases/24/12/b42350789/asana-announces-third-quarter-fiscal-2025-results">from the report. </a>
The Details: Asana reported quarterly losses of two cents per share, which beat the analyst consensus estimate for losses of seven cents. Quarterly revenue came in at $183.88 million, which beat the consensus estimate of $180.66 million and is an increase over sales of $166.5 million from the same period last year.
<ul>
<li>The number of Core customers, or customers spending $5,000 or more on an annualized basis, grew to 23,609, an increase of 11% year-over-year. </li>
<li>Revenues from Core customers grew 11% year-over-year. </li>
<li>The number of customers spending $100,000 or more on an annualized basis grew to 683, an increase of 18%. </li>
<li>Overall dollar-based net retention rate was 96%. </li>
<li>Dollar-based net retention rate for Core customers was 98%. </li>
<li>Dollar-based net retention rate for customers spending $100,000 or more on an annualized basis was 99%.</li>
</ul>
Read Next: <a href="https://www.benzinga.com/24/12/42316904/unitedhealthcare-ceo-brian-thompson-dies-after-being-shot-outside-nyc-hotel">UnitedHealthcare CEO Brian Thompson Fatally Shot Outside NYC Hotel</a>
&#8220;The launch of AI Studio is the birth of a new category, unlocking a massive Total Addressable Market (TAM) and growth opportunity for the company,&#8221; said Dustin Moskovitz, CEO of Asana. 
&#8220;While still early, we have seen significant demand, with customers experiencing meaningful productivity gains across their workflows. The productivity benefits and early traction not only validate the market demand for AI-powered work management solutions but also underscore Asana&#8217;s leadership position in this space,&#8221; Moskovitz added. 
Outlook:&nbsp;Asana sees fiscal 2025 adjusted losses of 15 cents to 14 cents per share, versus the loss of 19 cents estimate, and revenue of $723 million to $724 million, versus the $720.25 million estimate. 
ASAN Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Asana shares are up 20.44% after-hours at $18.62 at the time of publication Thursday. 
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/24/12/42300548/art-cashins-lessons-cuban-crisis-trades-to-timeless-wall-street-wit">Art Cashin&#8217;s Lessons: Cuban Crisis Trades To Timeless Wall Street Wit</a></li>
</ul>
Image: Shutterstock

Earnings

After-Hours Center

Movers

Tech

ASAN

Asana Shares Rally After Strong Q3 Results, Upbeat Guidance: Details

National Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIZZ#NASDAQ">FIZZ</a>) reported quarterly earnings of $0.49 per share which missed the analyst consensus estimate of $0.51 by 3.92 percent. This is a 4.26 percent increase over earnings of $0.47 per share from the same period last year. The company reported quarterly sales of $291.00 million which missed the analyst consensus estimate of $309.98 million by 6.12 percent. This is a 3.02 percent decrease over sales of $300.07 million the same period last year.

Earnings Misses

FIZZ

National Beverage Q2 EPS $0.49 Misses $0.51 Estimate, Sales $291.00M Miss $309.98M Estimate

Mercurity Fintech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MFH#NASDAQ">MFH</a>) reported $517.18 thousand in sales this quarter. This is a 110.03 percent increase over sales of $246.24 thousand the same period last year.

Mercurity Fintech Holding H1 Sales $517.18K Up From $246.24K YoY

Shield AI, the defense technology company building autonomy for the world, has announced it is expanding its work with&nbsp;Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), a leading provider of AI systems, to develop and deliver large-scale command and control of autonomous uncrewed systems, including operations in GPS- and communications-denied environments. With Warp Speed, Palantir's manufacturing OS for American re-industrialization, Shield AI is doubling down on its commitment to delivering scalable, AI-powered solutions to protect service members and civilians.

PLTR

Shield AI Expands Its Work With Palantir Technologies To Develop And Deliver Large-Scale Command And Control Of Autonomous Uncrewed Systems, Including Operations In GPS- And Communications-Denied Environments

&nbsp;GoDaddy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDDY#NYSE">GDDY</a>) announced Go Daddy Operating Company, LLC and GD Finance Co, LLC (together with Go Daddy Operating Company, LLC, the "Borrowers") allocated a $1,463 million tranche (the "Replacement Term Loans") of term loans maturing in 2029, the proceeds of which will be used to refinance all outstanding Tranche B-6 Term Loans under the Second Amended and Restated Credit Agreement, dated as of February 15, 2017 (as amended, restated, supplemented or otherwise modified, refinanced or replaced from time to time, the "Credit Agreement"), by and among the Borrowers, Desert Newco, LLC, the lenders and the other parties thereto (such refinancing, the "Term Loan Refinancing"). Capitalized terms used herein, but not otherwise defined herein are as defined in the Credit Agreement.
The foregoing transactions are subject to conditions and are anticipated to close in the fourth quarter of 2024. However, there can be no assurance that the Borrowers will be able to successfully complete the transactions, on the terms described above, or at all.

Financing

GDDY

GoDaddy Inc. Announces It Allocated A $1.463B Tranche Of Term Loans Maturing In 2029, The Proceeds Of Which Will Be Used To Refinance All Outstanding Tranche B-6 Term Loans

MISTRAS Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MG#NYSE">MG</a>)—a leading "one source" multinational provider of integrated technology-enabled asset protection solutions—today announced that the Company's Board of Directors has appointed Natalia Shuman as MISTRAS Group's new President and Chief Executive Officer (CEO), effective January 1, 2025.
Ms. Shuman brings over two decades of leadership experience to MISTRAS Group, having held executive roles at prominent global organizations in the Testing, Inspection, and Certification (TIC) industry. Most recently, as Group Executive Vice President and Group Operating Council Member for Eurofins Scientific, she led over 12,000 employees, driving growth strategies, operational excellence, and strategic value creation. Known for scaling billion-dollar enterprises through organic growth and M&amp;A, Ms. Shuman has a proven track record of fostering strong teams and delivering innovative, value-driven solutions.

MISTRAS Group Appoints Natalia Shuman As President And Chief Executive Officer, Effective January 1, 2025

Net proceeds to be used towards partial repayment of the Company's senior secured non-convertible debentures issued inJuly2023
MONTREAL, Dec. 5, 2024 /PRNewswire/ - The Lion Electric Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEV#NYSE">LEV</a>) (TSX:<a class="ticker" href="https://www.benzinga.com/stock/LEV#TSX">LEV</a>) ("Lion" or the "Company"), a leading manufacturer of all-electric medium and heavy-duty urban vehicles, announced today that it has reached a definitive agreement with Aéroport de Montreal to sell its innovation center facility located in Mirabel, Québec, for a purchase price of C$50,000,000, subject to customary purchase price adjustments and closing conditions.

Asset Sales

TSX:LEV

Lion Electric Reaches Definitive Agreement In Respect Of The Sale Of Innovation Center Located In Mirabel, Québec For A Purchase Price Of C$50 Million; Net Proceeds To Be Used Towards Partial Repayment Of The Co's Senior Secured Non-Convertible Debentures Issued In July 2023

Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>) announced that it has entered into share repurchase agreements in the&nbsp;U.S.&nbsp;and Hong Kong&nbsp;for an aggregate repurchase amount of approximately US$360 million&nbsp;for the first half of 2025, commencing&nbsp;on&nbsp;January&nbsp;6,&nbsp;2025.
The share repurchase agreements include approximately US$290 million&nbsp;under the Rule 10b5-1 of the United States Securities Exchange Act of 1934 in the&nbsp;U.S.&nbsp;and approximately HK$550 million&nbsp;for a similar program in&nbsp;Hong Kong. These agreements are one component of the share repurchase program, and part of the broader capital allocation plan to return&nbsp;US$4.5 billion&nbsp;to shareholders through dividends and share repurchases from 2024 to 2026, including US$1.5 billion for the full year 2024.
In the first 11 months of 2024, the Company returned a record US$1.37 billion to shareholders, including US$1.18 billion in share repurchases and US$187 million in cash dividends. A total of 30 million shares have been bought back, equivalent to approximately 7% of its outstanding shares as of December 31, 2023.

Buybacks

YUMC

Yum China Entered Into Share Repurchase Agreements In The U.S. And Hong Kong For An Aggregate Repurchase Amount Of ~$360M For 1H 2025, Commencing On January 6, 2025

Genesis Energy, L.P. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEL#NYSE">GEL</a>) announced today, in connection with our previously announced cash tender offer (the "Tender Offer") for our 8.0% Senior Notes due 2027 ( "Notes"), that we have increased the maximum aggregate principal amount of Notes that we will accept for purchase in the Tender Offer from $385 million to $575 million (as hereby amended, the "Tender Offer Cap"), on the terms and conditions of the offer to purchase, dated as of December 5, 2024 (as amended by the terms set forth herein, the "Offer to Purchase").

Offerings

Genesis Energy, L.P. Announces Increase To Previously Announced Tender Offer For Its 8.0% Senior Notes Due 2027 From $385M To $575M

OSI Systems, Inc. (the "Company" or "OSI") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSIS#NASDAQ">OSIS</a>) announced today that, following a search process, its Board of Directors has appointed Ajay Mehra, current President of OSI's Security division and Executive Vice President of OSI, as the Company's new President and Chief Executive Officer, effective January 1, 2025. Mr. Mehra will succeed Deepak Chopra, who will transition to Executive Chairman of the Board.

OSIS

OSI Systems Names Ajay Mehra To Succeed Deepak Chopra As President And CEO, Effective January 1, 2025

Innovative Food Holdings, Inc. (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/IVFH#OTCQB">IVFH</a>) ("IVFH" or the "Company"), a national seller of gourmet specialty foods to professional chefs, today announced significant corporate updates, including a planned name change to Harvest Group Holdings, Inc., the stockholder approval of a reverse stock split, and the successful execution of securities purchase agreements (the "SPA") for a private placement (the "Private Placement") to raise $3.25 million in new equity capital.
Strategic Updates in preparation for Nasdaq uplisting
<ul>
<li>Name Change: Over the last year and a half, CEO Bill Bennett and his team have dramatically changed the focus and business model of the Company. These actions have included divesting, inactivating, or shutting down eight previously operating entities within the corporate structure, while simultaneously launching a new large retail business and new customers within its drop ship business. Accordingly, the Company will rebrand as Harvest Group Holdings, Inc. to reflect its growth strategy and new focus. The new name underscores IVFH's commitment to its vision of delivering fresh and artisanal products from as close to the source as possible, while still being a broad enough brand to encompass the many growth opportunities ahead. The Company website, logo, and other Company branding will be updated over the coming weeks after the finalization of the name change.</li>
<li>Reverse Stock Split: The Board and the holders of a majority of the Company's issued and outstanding stock have authorized a reverse stock split of the Company's common stock at a ratio between one-for-three and one-for-seven, which may enable the Company's share price to meet the stock price element of the initial listing requirements of The Nasdaq Capital Market ("Nasdaq").</li>
<li>Private Placement Financing: Under the SPA, the Company will issue 2,031,250 shares of common stock at $1.60 per share, raising gross proceeds of $3.25 million. The capital raised will be used to enhance working capital and fund general corporate purposes. This modest raise, largely from Company insiders, is intended to help the Company continue to lean into its growth opportunities, and meet the minimum shareholder equity requirements of Nasdaq.</li>
<li>Nasdaq Uplisting: With the above actions, the Company management believes the Company is in a strong position to navigate the uplisting process, which it is kicking off in earnest. Pending all necessary approvals, the Company hopes to complete the uplisting process in the first half of 2025.</li>
</ul>

Stock Split

IVFH

Innovative Food Holdings Announces Corporate Name Change To Harvest Group Holdings, Inc., A Reverse Stock Split In The Ratio Between 1-For-3 and 1-For-7, And $3.25M Private Placement Of 2,031,250 Shares Of Common Stock At A Price Of $1.60/Share In Preparation For Uplisting To Nasdaq

BASE SHELF PROSPECTUS IS ACCESSIBLE, AND PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS, ON SEDAR+ AND ON EDGAR
TORONTO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/PRN#TSX">PRN</a>, NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROF#NASDAQ">PROF</a>) ("Profound" or the "Company") today announced that it intends to offer and sell common shares (the "Common Shares") in an underwritten public offering (the "Offering"). In addition, Profound expects to grant the underwriters of the Offering a 30-day option to purchase up to an additional 15% of the Common Shares sold in the Offering. All of the securities in the Offering are being offered by Profound. The Offering is subject to market conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.
The net proceeds of the Offering are expected to be used: (i) to fund the continued commercialization of the TULSA-PRO&#xAE; system in the United States, (ii) to fund the continued development and commercialization of the TULSA-PRO&#xAE; system and the Sonalleve&#xAE; system globally, and (iii) for working capital and general corporate purposes.
The Offering is expected to be completed pursuant to an underwriting agreement to be entered into between the Company and Raymond James Ltd. and Lake Street Capital Markets as co-lead underwriters and joint bookrunners, and a third underwriter. The Offering is expected to take place in each of the provinces and territories of Canada, except the province of Québec, and in the United States.
The Offering is expected to close on or about December 10, 2024, subject to customary closing conditions including, but not limited to, the receipt of all necessary approvals including the approval of the Toronto Stock Exchange. Profound will notify the Nasdaq Capital Market in accordance with the rules of that exchange.

PROF

TSX:PRN

Profound Medical Announces Proposed Public Offering Of Common Shares; No Size Or Amount Disclosed

Maxeon Solar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAXN#NASDAQ">MAXN</a>) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(2.52) by 81.35 percent. This is a 78.73 percent increase over losses of $(2.21) per share from the same period last year. The company reported quarterly sales of $88.56 million which missed the analyst consensus estimate of $102.80 million by 13.85 percent. This is a 61.09 percent decrease over sales of $227.63 million the same period last year.

Earnings Beats

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

Maxeon Solar Technologies Q3 EPS $(0.47) Beats $(2.52) Estimate, Sales $88.56M Miss $102.80M Estimate

Rubrik Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) reported third-quarter financial results after the market close on Thursday. Here&#8217;s a <a href="https://www.benzinga.com/pressreleases/24/12/b42350621/rubrik-reports-third-quarter-fiscal-year-2025-financial-results">rundown of the report</a>.
<ul>
<li>Q3 Revenue: $236.2 million, versus <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $217.52 million</li>
</ul>
<ul>
<li>Q3 Adjusted EPS: Loss of 21 cents, versus estimates for a loss of 40 cents</li>
</ul>
Total revenue was up 43% year-over-year. The data security company said annual recurring revenue (ARR) increased 38% year-over-year to $1.002 billion. Rubrik ended the quarter with 2,085 customers with $100,000 or more in subscription ARR, up 32% year-over-year.
Cash flow from operations was&nbsp;$23.1 million and free cash flow came in at&nbsp;$15.6 million, up from&nbsp;$3.5 million&nbsp;in the prior year&#8217;s quarter. The company ended the quarter with $632 million in cash, cash equivalents and short-term investments. 
&#8220;We&#8217;re incredibly proud to have surpassed&nbsp;$1 billion&nbsp;in Subscription ARR, growing&nbsp;38%&nbsp;year-over-year. This is a significant milestone achieved in just over 10 years since the company was founded,&#8221; said Bipul Sinha, chairman, co-founder and CEO of Rubrik.
&#8220;Our strong growth at scale shows that we&#8217;re winning the cyber resilience market and we&#8217;re excited to continue to execute on this new vision to define the future of the cybersecurity industry.&#8221; 
What&#8217;s Next: Rubrik expects fourth-quarter revenue to be in the range of $231.5 million to $233.5 million versus estimates of $225.07 million. The company anticipates a fourth-quarter adjusted loss of 37 cents to 41 cents per share versus estimates for a loss of 41 cents per share, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Management will further discuss the quarter on a call with analysts and investors at 5 p.m. ET.
RBRK Price Action: <a href="http://benzinga.com/quote/rbrk">Rubrik shares</a> were up 14.18% in after-hours, trading at $61.27 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next: • <a href="https://www.benzinga.com/news/buybacks/24/12/42352166/lululemon-q3-earnings-revenue-beat-eps-beat-1b-buyback-increase-continued-momentum-across-international-markets">Lululemon Q3 Earnings: Revenue Beat, EPS Beat, $1B Buyback Increase, &#8216;Continued Momentum&#8217; Across International Markets</a>
This illustration was generated using artificial intelligence via Midjourney.

Guidance

RBRK

Rubrik Stock Jumps On Strong Q3 Print: Key Details

ENDRA Life Sciences (NDRA) just unveiled an announcement. ENDRA Life Sciences Inc. has announced that they've received additional time from a Nasda...

ENDRA Life Sciences Strives for Nasdaq Compliance

ENDRA Life Sciences (NDRA) Inannounces the activation of a post market clinical study and first patient scanned with the TAEUS liver system at LMU ...

Endra activates TAEUS system to initiate clinical study at LMU in Germany

19:50 EST ENDRA Life Sciences (NDRA) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving ...

ENDRA Life Sciences Inc trading halted, news pending

09:33 EST ENDRA Life Sciences (NDRA) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, ma...

ENDRA Life Sciences Inc trading halted, volatility trading pause

Endra Life Sciences GAAP EPS of -$9.54

Endra Life Sciences ( ($NDRA) ) has released its Q3 earnings. Here is a breakdown of the information Endra Life Sciences presented to its investors...

ENDRA Life Sciences Reports Q3 2024 Results and Progress

Endra Life Sciences (NDRA) announced that it has regained compliance with the minimum bid price requirement set forth by Nasdaq. Published first on...

Endra Life Sciences regains compliance with Nasdaq

ENDRA Life Sciences regains compliance with Nasdaq's listing rule

11:10 EST ENDRA Life Sciences (NDRA) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking fina...

ENDRA Life Sciences Inc trading resumes

11:05 EST ENDRA Life Sciences (NDRA) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, ma...

Comments

ENDRA Life Sciences

ENDRA Life Sciences (NDRA) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO